Correlation Between Gracell Biotechnologies and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Gracell Biotechnologies and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gracell Biotechnologies and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gracell Biotechnologies and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Gracell Biotechnologies and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gracell Biotechnologies with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gracell Biotechnologies and Mineralys Therapeutics,.
Diversification Opportunities for Gracell Biotechnologies and Mineralys Therapeutics,
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Gracell and Mineralys is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Gracell Biotechnologies and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Gracell Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gracell Biotechnologies are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Gracell Biotechnologies i.e., Gracell Biotechnologies and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Gracell Biotechnologies and Mineralys Therapeutics,
Given the investment horizon of 90 days Gracell Biotechnologies is expected to generate 1.6 times more return on investment than Mineralys Therapeutics,. However, Gracell Biotechnologies is 1.6 times more volatile than Mineralys Therapeutics, Common. It trades about 0.06 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about 0.01 per unit of risk. If you would invest 287.00 in Gracell Biotechnologies on August 26, 2024 and sell it today you would earn a total of 115.00 from holding Gracell Biotechnologies or generate 40.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 35.18% |
| Values | Daily Returns |
Gracell Biotechnologies vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Gracell Biotechnologies |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Mineralys Therapeutics, |
Gracell Biotechnologies and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gracell Biotechnologies and Mineralys Therapeutics,
The main advantage of trading using opposite Gracell Biotechnologies and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gracell Biotechnologies position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Gracell Biotechnologies vs. Monte Rosa Therapeutics | Gracell Biotechnologies vs. Design Therapeutics | Gracell Biotechnologies vs. Erasca Inc | Gracell Biotechnologies vs. NextCure |
| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |